Objective: Dopaminergic neurotransmission is known to be a potential modulator of risky behaviors including substance abuse, promiscuity, and gambling. Furthermore, observational studies have shown associations between risky behaviors and Parkinson's disease; however, the causal nature of these associations remains unclear. Thus, in this study, we examine causal associations between risky behavior phenotypes on Parkinson's disease using a Mendelian randomization approach.
Introduction
Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder characterized pathologically by progressive loss of dopaminergic neurons in the substantia nigra 1 . The currently available treatment options for PD are symptomatic only. The lack of disease-modifying or protective treatments is at least in part due to the fact that the exact disease mechanisms are currently only partly understood.
The vast majority of PD cases are caused by the combined action and likely interaction of genetic variants as well as environmental and lifestyle exposures [2] [3] [4] [5] [6] . Several common habitual agents like smoking, coffee and alcohol drinking have shown protective associations with PD in large scale meta-analyses of observational studies 7 . Several recent studies have further shown beneficial effects of cannabidiol, a non-psychotomimetic compound derived from cannabis on non-motor symptoms in PD patients 8 . It is noteworthy that several impulse control disorders (ICDs) such as gambling, hypersexuality and compulsive eating are observed more frequently in PD patients with some studies reporting up to 40% prevalence of ICDs in PD patients 9 . However, it is believed that these symptoms may be the result of dopamine agonist therapy prescribed to PD patients 10 . The imminent challenge in this context is to decipher whether these PD-associated environmental/lifestyle/behavioral variables contribute to or are an effect of the disease.
The recent development of the Mendelian randomization (MR) approach allows to judge causality based on genetic data generated in observational studies. Specifically, this relies on the utilization of genetic variants as proxy markers of risk factors 11 and takes care of confounding by exploiting random allocation of genetic variants at birth. We have also seen a surge of MR studies in the field of PD specifically exploring the causal role of several circulating biomarkers [12] [13] [14] [15] [16] [17] [18] . For example, a recent MR study reported a significant causal association with a lifelong PD risk reduction of 3% per 10 µg/dl increase in serum iron levels 14 . Most recently, another study further reported a risk reduction of 18% with a lifetime exposure of 5kg/m2 higher BMI 15 .
To date, the majority of studies in the field of PD have focused on modifiable environmental factors only, and MR studies exploring the role of behavioral phenotypes are lacking. Henceforth, our primary aim was to investigate the willingness to take risk as a causal factor in the development of PD.
For this, we applied a two-sample MR to investigate whether people with risk taking tendency have an altered risk for PD 19 . A recent GWAS identified 611 independent loci with several measures of risky behaviors including general risk tolerance, adventurousness, and risky behaviors in the driving, drinking, smoking, and sexual domains 20 . We used all reported loci to mimic the random allocation of loci among PD cases and controls in available data from a large, recent GWAS on PD 4, 21 . As secondary analyses, we further considered the wider literature to support inferences drawn from our primary analysis using previously reported GWAS on similar habitual behaviors such as smoking phenotypes, coffee consumption, alcoholism, cannabis dependence and gambling [22] [23] [24] [25] [26] [27] .
Methods

Study design and identification of datasets
We conducted a two-sample MR using summary level estimates to explore the causal role of several risky behaviors on PD 28 . We identified genetic instruments that influence risky behaviors using a recently published meta-analysis of GWAS datasets on risky behaviors 20 . The study reported statistically significant associations of 611 independent loci (p-value<5x10 -8 ) in a discovery cohort in up to 939,908 individuals of European ancestry with six highly correlated risky behavior phenotypes including general risk tolerance, adventurousness, automobile speeding propensity, drinks per week, ever versus never smoking and number of sexual partners. The study further defined general risk tolerance as the willingness to take risks, "adventurousness" as the self reported tendency to be adventurous vs. cautious, "automobile speeding propensity" as the tendency to drive faster than the speed limit, "drinks per week" as the average number of alcoholic drinks consumed per week, "ever smoker (tendency to smoke)" as whether one has ever been a smoker, and lastly "number of sexual partners" as the lifetime number of sexual partners.
We further extracted summary estimates of the identified genetic variants from the discovery cohort of a recent meta-analysis of GWAS on 9581 PD cases and 33, 245 controls of European ancestry 4 . For this, we used data available on the PDGene database (http://www.pdgene.org) 21 .
Genetic instruments were identified for smoking (cigarettes per day), smoking initiation, smoking cessation, cannabis dependence, pathological gambling, alcohol and coffee consumption from independent GWAS as a part of our secondary analyses [22] [23] [24] [25] [26] [27] .
Prioritization of genetic variants and power analysis
We systematically screened all the identified loci for a possible direct involvement in PD. For this, we used data available via PDGene to extract the list of loci shown to be significantly associated with PD (p-value<5x10 -8 )
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. We further checked overlapping loci for a relevant role in the pathogenesis of PD using a literature search. If substantial evidence was found, the respective loci were excluded from the list of genetic variants (SNPs, genetic instrument) of the respective behavioral traits.
The SNPs constituting each genetic instrument were checked for strong linkage disequilibrium (LD). We used the rAggr database to look for correlated variants in individuals with European descent from the 1000 Genomes Phase 3 data (http://raggr.usc.edu; date last accessed June 22, 2018) and excluded one of the variants for pairs with R 2 greater than 0.25. Finally, if SNPs were not available in the PD GWAS dataset, we identified proxy SNPs using an R 2 cut-off of 0.9 based on the rAggr database as above.
The strength of the prioritized genetic instrument was judged using F-statistics as explained earlier 14 . We computed the variance in exposures explained by prioritized genetic instruments (R 2 ) of the genetic insturments using effect estimates and the standard error of individual SNPs as described elsewhere
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. Lastly, power calculations were done using the method described by Brion et al., which is available online http://cnsgenomics.com/shiny/mRnd/) 30 .
Estimation of causal effects
In cases where the genetic instruments comprised a single SNP, we used the Wald ratio estimate along with the Delta method to obtain the related estimate of the variance. In cases where the genetic instruments consisted of multiple SNPs, we used the inverse variance weighted (IVW) fixed effect method as the main method to estimate the effect of genetically predicted behavioral phenotypes on PD by combining the genetic loci-specific Wald ratio estimates. We specifically employed the IVW method using second order weights because casual estimates generated through this method are expected to provide a more accurate reflection of the variance of the Wald ratio estimate 31 .
However, in the absence of reliable information on functional pathways, proportion and direction of pleiotropic genetic variants, additional MR methods including MR-Egger, Weighted median and Weighted mode-based method were also employed to check the consistency of direction of effect estimates 19, [32] [33] [34] . Unlike IVW, which assumes no intercept term in the model, the MR-Egger method provides less biased causal estimates in the presence of directional pleiotropy and considerable heterogeneity assuming absence of measurement error (NOME assumption) 19 . However, the MREgger method is more sensitive to unobserved associations of genetic variants with confounders of the exposure-outcome association and requires a greater sample size for the same underlying variance in exposure 33 . Both IVW and MR-Egger methods further assume that the pleiotropic effects of genetic variants are independent of their associations with the exposure known as the InSIDE assumption. In the case of violation, the Weighted median method may provide consistent causal estimates even if up to 50% of genetic variants do not conform to the InSIDE assumption. Also the Weighted mode-based method may provide consistent causal estimates, in particular, even when the NOME assumption was not met, but assuming that the most frequent value of the bias of the Wald ratio estimates is zero.
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Within every MR method, we computed casual estimates as odds ratio (OR) for PD per unit log of odds of the categorical behavioral phenotypes or OR per unit standard deviation (SD) of the continuous behavioral phenotypes. And lastly, to address the issue of multiple testing, results were considered statistically significant at the 5% level after a conservative Bonferroni correction of the significance level, therefore if p-value<8.3×10 -3 (0.05/6 independent primary MR hypotheses).
Assessment of pleiotropy
We used the Cochran Q-statistic and I 2 for the IVW method using second order weights as 
Sensitivity analyses
A leave-one-out sensitivity analysis was conducted to check for a disproporationate influence of individual SNPs on overall causal effect estimates using the IVW method. We used forest plots to visually assess the results of the analysis and further identify the outliers.
Since all the behavioral traits are highly correlated and are expected to exhibit shared genetic influence, we conducted a sensitivity analysis by including only genetic loci specific to each individual behavioral trait. We used an R 2 >0.8 to consider loci to be overlapping with other loci in an independent genetic instrument. Such an approach may help us to judge the reliability of independent associations of observed phenotypic traits. We further adopted a conservative approach by using loci unique to each phenotypic trait (R 2 <0.01) at the cost of reduced power.
We used Phenoscanner database to identify potential pleiotropic variants by checking significant associations of loci prioritized in the present study with phenotypes from previously published GWAS 
Results
Prioritization of genetic instruments and power analysis
The descriptive statistics of the genetic instruments selected for the MR analyses are presented in 
Estimation of causal effects and assessment of pleiotropy
The causal effect estimates using different MR methods are provided in Figure 2 .
Sensitivity analyses
Leave-one-out analysis
Based on the forest plots, we observed outlier SNPs for the phenotypes general risk tolerance (rs993137), adventurousness (rs10433500) and drinks per week (rs1229984) (data not shown). 
Genetic overlap between risky behaviors
We identified a reduction in the number of unique SNPs in the genetic instruments for each of the phenotypes using two different LD cut-offs (R 
Geneticvariants associated with potential confounders
We did a comprehensive screening of the the Phenoscanner database for potential associations of genetic loci used in the current study and reported to be associated with other phenotypes. The identified associated phenotypes were then investigated for association with PD based on a thorough literature search. Using this strategy, we identified rheumatoid arthritis, years of educational attainment, adiposity related traits, age at menarche and type I diabetes as potential confounders [41] [42] [43] [44] [45] ( Figure 2) . We identified eight genetic variants or loci from our genetic instrument for the tendency to smoke phenotype associated with different confounding traits. SNP rs12042017 has been previously reported to be associated with years of educational attainment (p-value=4.48x10 -10 ). SNPs rs13396935 and rs6265 were observed to be associated with several adiposity related measures. The proxy variant rs1514174 of rs4650277 (R 2 =0.99) was further associated with ).
Rheumatoid arthritis, age at menarche and type I diabetes were further identified as potential confounders associated with rs2734971, rs4650277 and rs1701704 (proxy for rs772921 with complete LD). Our sensitivity analysis excluding each of the SNPs or combinations of SNPs based on their common associated trait showed no overall influence on causal effect estimate for the tendency to smoke phenotype (data not shown).
Geneticvariants involved in brain expression
Using brain-specific expression quantitative trait loci (eQTL) retrieved from GTEx, we identified 27 different SNPs from the genetic instrument for the tendency to smoke phenotype with varied influence in different brain regions (data not shown). Suprisingly, the corresponding candidate genes were least represented in the substantia nigra, while as many as 10 genetic variants were observed to significantly influence gene expression in cerebellar hemisphere as well as cerebellum.
Our sensitivity analysis showed that excluding genetic variants mapping to genes over-expressed in the cerebellum had maximum influence on the overall causal effect estimation (OR=0.761; 95%
CI=0.606-0.957; p-value=0.0197). A similar influence was observed after excluding all the genetic variants mapping to genes expressed in brain (OR=0.735; 95% CI=0.581-0.930; p-value=0.0106). Our sensitivity analysis thereby suggested an important role of the cerebellum in the smoking tendency phenotype. Our literature search for the excluded genetic variants in the tendency to smoke genetic instrument influencing expression in cerebellum for potential influence on other biological pathways rules out pleiotropic effect of these variants.
Secondary MR analysis
The descriptive statistics of the genetic instruments selected for the secondary MR analyses are presented in Table 4 . The causal effect estimates are shown in Caucasians further reported absence of any significant SNPs with pathological gambling 26 . We generated a genetic instrument based on the top hits from the study with a P-value cut off of <10 -4 employing 45 uncorrelated genetic variants. We observed no causal association of PD with pathological gambling (OR=1.004; 95% CI=0.991-1.018; p-value=0.5120).
Discussion
To the best of our knowledge, this is the first comprehensive study exploring the role of risky behaviors as causal factors for PD using a MR approach. The study suggests that the tendency-tosmoke trait is causally related to PD with individuals who started smoking being protected against PD.
Our sensitivity analysis further demonstrated robustness of the reported association in the absence of any detectable pleiotropic effect. Furthermore, our secondary MR analysis did not show any causal association of other habitual traits including other smoking phenotypes such as number of cigarettes per day, cannabis dependence, pathological gambling, alcohol and coffee consumption with PD.
Numerous observational studies have previously shown an inverse association of smoking with PD. A meta-analysis merging smoking status trait from 33 different populations demonstrated a risk reduction by 36% for ever-vs never-smokers with consistent results in both case-control and cohort studies 2 . Other epidemiological studies suggested significant gene-by-smoking interaction effects in PD 46, 47 . In our study, we observed a PD risk reduction of 31% for ever smokers vs never smokers. Although risk reduction effects demonstrated in an observational and in an MR study may not be comparable, a consistency in the direction of protective associations by both the approaches is an important finding.
To validate our results, we performed secondary MR analyses using other habit-related behaviors from other GWAS. The lack of association with a previously reported genetic instrument for ever smoker instrument as well as fomer smoker vs. current smoker may be explained by lower power of the GWAS with only one significant variant contributing to the instrument for both MR analyses. We also did not observe an association of PD risk and the number of cigarettes per day. One explanation would be that this continuous phenotype mainly just reflects the tobacco and nicotine exposure, whereas the ever vs never smoking might rather be a sign of risk taking behaviour. Our results thereby clearly imply the need for careful dissection of different smoking phenotypes. This will help understanding the causal role of the tendency to smoke on PD and reveal further insight into the development of the disease.
As outlined in the results section, our MR results on coffee consumption (cups per week) and alcohol consumption (drinks per week) also did not show significant causal associations. However, we cannot exclude that the analysis of coffee and alcohol consumption as quantitative traits may have the same limitations as the analysis of cigarettes smoked per day. Lastly, lack of a causal role of cannabis dependence observed in the present study needs to be further evaluated with stronger genetic instruments.
Absence of association with gambling in our analysis, however, could be attributed to the winner's curse as SNP-exposure estimates used for calculation of casual estimates may be overestimated due to limited power of the study on gambling phenotype. Another important finding of our comprehensive MR analyses was absence of any causal role of drinks per week with PD. Using data from the UK biobank, we were able to replicate our finding of absence of a causal association of alcohol consumption with risk of PD. However, our study suggests a potential causal association of the number of sexual partners and PD risk. To the best of our knowledge, no epidemiological population-based study has yet examined the role of promiscuity on PD risk. Therefore, our MR results need to be interpreted cautiously and independent lines of validation of this association are required to confirm these results.
An important limitation of our current study is that we could not directly assess associations of individual genetic variants with potential confounders of association between risk behavior and PD due to the lack of knowledge of potential confounders and unavailability of individual-level data.
Nevertheless, our sensitivity analysis demonstrated that exclusion of loci being associated with PD-associated phenotypes from the MR analyses had no effect on the overall association. We could not further provide data on the degree of sample overlap among GWAS datasets on exposure and outcome in our two-sample MR design. A considerable ovelap could bias the results towards the estimates generated through observational studies. However, this potential limitation could not have any impact on our results as the IVW method using second order weights employed in the current study is known to address this bias. And lastly, before drawing conclusions on the role of risky behavior on PD, we must recognize a critical limitation of our study that we could not do a stratified MR analysis based on dopaminergic treatment in cases as dopaminergic agonists are known to modulate risky behavior in PD patients.
Despite these limitations, to our knowledge, our study represents the most comprehensive MR study to date on risky behavior phenotypes and PD. An extensive sensitivity analysis including use of genetic instruments specific to individual phenotypic traits, use of previous studies, literature search for potential pleiotropic variants and brain expression analysis collectively demonstrate a strong causal protective role of smoking tendency on PD. Furthermore, the role of automobile speeding propensity as a causal risk factor emphasizes the need for a stratified MR based on dopamine-agonist treatment.
The present study also demonstrates that careful interpretation of pleiotropic signals and sensitivity analysis based on biological function could lead to fine filtering of GWAS signals. Such an approach may assist in differentiating between mediators and exposures, thereby helping us to construct the causal pathways leading to PD 48 .
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